ZA935879B - Method of inhibiting cell proliferation using apolipoprotein E. - Google Patents

Method of inhibiting cell proliferation using apolipoprotein E.

Info

Publication number
ZA935879B
ZA935879B ZA935879A ZA935879A ZA935879B ZA 935879 B ZA935879 B ZA 935879B ZA 935879 A ZA935879 A ZA 935879A ZA 935879 A ZA935879 A ZA 935879A ZA 935879 B ZA935879 B ZA 935879B
Authority
ZA
South Africa
Prior art keywords
apolipoprotein
cell proliferation
inhibiting cell
inhibiting
proliferation
Prior art date
Application number
ZA935879A
Other languages
English (en)
Inventor
Tikva Vogel
Amos Panet
Original Assignee
Bio Technology General Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Technology General Corp filed Critical Bio Technology General Corp
Publication of ZA935879B publication Critical patent/ZA935879B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA935879A 1992-08-12 1993-08-12 Method of inhibiting cell proliferation using apolipoprotein E. ZA935879B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92897992A 1992-08-12 1992-08-12

Publications (1)

Publication Number Publication Date
ZA935879B true ZA935879B (en) 1994-03-11

Family

ID=25457115

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA935879A ZA935879B (en) 1992-08-12 1993-08-12 Method of inhibiting cell proliferation using apolipoprotein E.

Country Status (9)

Country Link
EP (1) EP0659085A4 (xx)
JP (1) JPH08502730A (xx)
KR (1) KR950702430A (xx)
AU (1) AU673543B2 (xx)
CA (1) CA2141598A1 (xx)
IL (1) IL106664A0 (xx)
NZ (1) NZ255732A (xx)
WO (1) WO1994004178A1 (xx)
ZA (1) ZA935879B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
IL110638A0 (en) * 1993-08-12 1994-11-11 Bio Technology General Corp Composition for inhibiting kaposi's sarcoma
IL120005A (en) * 1997-01-14 2000-08-31 Ramot University Authority Of Pharmaceutical compositions for the treatment of the eye
US6593291B1 (en) * 1997-02-06 2003-07-15 Entremed, Inc. Compositions and methods of use of ligands that bind components of the blood coagulation/clotting pathway for the treatment of cancer and angiogenic-based disease
AU4449900A (en) * 1999-03-17 2000-10-04 Entremed, Inc Compositions and methods of use of ldl-like receptor ligands for the treatment of cancer and angiogenic-based disease
WO2001037853A2 (en) * 1999-11-23 2001-05-31 North Shore - Long Island Jewish Health System Methods and agents for the inhibition of smooth muscle cell proliferation
US20020182587A1 (en) * 2001-03-02 2002-12-05 Sivaram Pillarisetti Methods and compositions for the treatment and prevention of smooth muscle cell proliferation
CN102137680A (zh) * 2008-07-01 2011-07-27 克格诺西有限公司 用apoe肽治疗癌症的方法
CA2823191A1 (en) 2010-01-06 2011-07-14 Cognosci, Inc. Apoe peptide dimers and uses thereof
WO2013042684A1 (ja) * 2011-09-20 2013-03-28 国立大学法人熊本大学 リポ蛋白を用いた神経疾患予防・治療剤ならびに神経疾患予防・治療方法
WO2022059703A1 (ja) * 2020-09-16 2022-03-24 国立大学法人大阪大学 がん治療用医薬、免疫賦活剤および抗がん物質のスクリーニング方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5168045A (en) * 1989-08-18 1992-12-01 The Scripps Research Institute Diagnostic systems and methods using polypeptide analogs of apolipoprotein e
US5473039A (en) * 1989-08-18 1995-12-05 The Scripps Research Institute Polypeptide analogs of apolipoprotein E, diagnostic systems and methods using the analogs
AU658578B2 (en) * 1991-06-26 1995-04-27 Bio-Technology General Corporation Purification of recombinant apolipoprotein E from bacteria
IL110638A0 (en) * 1993-08-12 1994-11-11 Bio Technology General Corp Composition for inhibiting kaposi's sarcoma

Also Published As

Publication number Publication date
JPH08502730A (ja) 1996-03-26
KR950702430A (ko) 1995-07-29
EP0659085A4 (en) 1996-06-12
IL106664A0 (en) 1993-12-08
EP0659085A1 (en) 1995-06-28
AU673543B2 (en) 1996-11-14
AU5007293A (en) 1994-03-15
CA2141598A1 (en) 1994-03-03
WO1994004178A1 (en) 1994-03-03
NZ255732A (en) 1997-05-26

Similar Documents

Publication Publication Date Title
IL108075A0 (en) Enzyme inhibitors
ZA945657B (en) Method to inhibit restenosis
EP0576178A3 (en) Method for maintaining the relationships between elements.
ZA939369B (en) Method of milling.
ZA94102B (en) Method of inhibiting viral reproduction
IL101792A0 (en) Bioreactor
GB9305142D0 (en) Method
GB9317513D0 (en) An improved airlock system
EP0608982A3 (en) Method of inhibiting endotoxin activity.
ZA935879B (en) Method of inhibiting cell proliferation using apolipoprotein E.
EP0599514A3 (en) Pyranoquinoline derivatives as inhibitors of cell proliferation.
PL313740A1 (en) Method of
GB9209175D0 (en) Bioreactor system
GB9214720D0 (en) Enzyme inhibitors
GB9306292D0 (en) Method
GR3022957T3 (en) Arrangement for cathodic protection
ZA942685B (en) Genetic stabilizing elements
GB9212261D0 (en) Enzyme cloning
ZA939480B (en) Enzyme inhibitor
GB9323819D0 (en) Anlytical method
AU2321088A (en) Method for preventing or treating thrombocytopenia
GB9324803D0 (en) Enzyme inhibitors
GB9324916D0 (en) Sludge biocombustion
GB9302488D0 (en) Cathodic protection system
ZA942247B (en) Method of construction